| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.23 | 0.5 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.23 | 0.6 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.24 | 0.1 |